Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Amortization of Deferred Charges (2020 - 2026)

Cresco Labs filings provide 7 years of Amortization of Deferred Charges readings, the most recent being $635000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 47.56% to $635000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.5 million, a 28.71% decrease, with the full-year FY2025 number at $4.1 million, down 16.4% from a year prior.
  • Amortization of Deferred Charges hit $635000.0 in Q1 2026 for Cresco Labs, down from $646000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.7 million in Q2 2025 to a low of $517000.0 in Q3 2025.
  • Median Amortization of Deferred Charges over the past 5 years was $1.1 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 86.35% in 2022 and later soared 38.91% in 2025.
  • Cresco Labs' Amortization of Deferred Charges stood at $1.0 million in 2022, then grew by 14.97% to $1.2 million in 2023, then rose by 3.53% to $1.2 million in 2024, then tumbled by 46.21% to $646000.0 in 2025, then fell by 1.7% to $635000.0 in 2026.
  • The last three reported values for Amortization of Deferred Charges were $635000.0 (Q1 2026), $646000.0 (Q4 2025), and $517000.0 (Q3 2025) per Business Quant data.